Status:
COMPLETED
Eisenmenger's Syndrome in Adults With CHD
Lead Sponsor:
Children's Healthcare of Atlanta
Conditions:
Congenital Disorders
Eligibility:
All Genders
18+ years
Brief Summary
Review the outcome of treatment with endothelin receptor antagonists (bosentan or sitaxsetan) alone or in combination with Sildenafil (a PDE-5 inhibitor) in adult patients with pulmonary hypertension ...
Detailed Description
The primary objective of this study is to examine medical records of patients with Eisenmenger's Syndrome in order to determine the effect of endothelin receptor antagonists, alone or in combination, ...
Eligibility Criteria
Inclusion
- Congenital heart disease (unoperated, palliated or repaired) Eisenmenger's syndrome Age 18 to 80
Exclusion
- Those who do not meet inclusion criteria
Key Trial Info
Start Date :
January 1 1996
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2008
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT00266903
Start Date
January 1 1996
End Date
January 1 2008
Last Update
December 2 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Healthcare of Atlanta
Atlanta, Georgia, United States, 30322